MedPath

Hematocrit Effect on a Blood Glucose Monitor

Not Applicable
Completed
Conditions
Diabetes Mellitus
Interventions
Diagnostic Test: blood glucose measurement, blood glucose monitor for personal use
Diagnostic Test: blood glucose measurement, laboratory reference device
Registration Number
NCT05158478
Lead Sponsor
Institut fur Diabetes Karlsburg GmbH
Brief Summary

This study assesses the repeatability precision of a blood glucose monitoring system pursuant to ISO 15197

Detailed Description

This study assesses the repeatability precision the blood glucose monitoring systems for personal use TJ100 pursuant to ISO 15197:2015 guidelines

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1
Inclusion Criteria
  • Male or female patients with clinical indication for blood glucose testing
  • Signed form of consent
  • Minimum age of 18 years
  • Subjects are legally competent and capable to understand character, meaning and consequences of the study
Exclusion Criteria
  • Pregnancy or lactation
  • Severe acute disease (at study physician's discretion)
  • Acute or chronic diseases with inherent risk of aggravation by the procedure (at study physician's discretion)
  • Current constitution that does not allow participating in the study (e.g. hematocrit out of
  • the devices's specifications, medication known to influence blood glucose measurements; Appendix A of ISO 15197)
  • Being unable to give informed consent
  • Age younger than 18 years
  • Legally incompetent

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Subject glucometer measurementblood glucose measurement, blood glucose monitor for personal use-
Subject glucometer measurementblood glucose measurement, laboratory reference device-
Primary Outcome Measures
NameTimeMethod
repeatability precisionday 1

Assessment of the analytical measurement performance of the blood glucose monitor based on procedures defined in DIN EN ISO 15197

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Institut für Diabetes Karlsburg GmbH

🇩🇪

Karlsburg, Mecklenburg Vorpommern, Germany

© Copyright 2025. All Rights Reserved by MedPath